IN2014CN03950A - - Google Patents

Info

Publication number
IN2014CN03950A
IN2014CN03950A IN3950CHN2014A IN2014CN03950A IN 2014CN03950 A IN2014CN03950 A IN 2014CN03950A IN 3950CHN2014 A IN3950CHN2014 A IN 3950CHN2014A IN 2014CN03950 A IN2014CN03950 A IN 2014CN03950A
Authority
IN
India
Prior art keywords
terpenoid
ophthalmological
polymer compound
inhibitory activity
aqueous composition
Prior art date
Application number
Other languages
English (en)
Inventor
Yasuko Matsumura
Chinatsu Furumiya
Masashi Itoh
Original Assignee
Rohto Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharma filed Critical Rohto Pharma
Publication of IN2014CN03950A publication Critical patent/IN2014CN03950A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN3950CHN2014 2011-11-01 2012-10-31 IN2014CN03950A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011240167 2011-11-01
PCT/JP2012/078128 WO2013065720A1 (ja) 2011-11-01 2012-10-31 眼科用水性組成物

Publications (1)

Publication Number Publication Date
IN2014CN03950A true IN2014CN03950A (ja) 2015-10-16

Family

ID=48192065

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3950CHN2014 IN2014CN03950A (ja) 2011-11-01 2012-10-31

Country Status (5)

Country Link
US (1) US9173945B2 (ja)
JP (2) JP6313599B2 (ja)
CA (1) CA2853235A1 (ja)
IN (1) IN2014CN03950A (ja)
WO (1) WO2013065720A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6313599B2 (ja) * 2011-11-01 2018-04-18 ロート製薬株式会社 眼科用水性組成物
JP2016185940A (ja) * 2014-06-10 2016-10-27 ロート製薬株式会社 眼科用組成物
JP2017197524A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
US11331390B2 (en) 2016-04-22 2022-05-17 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition
JP2017197526A (ja) * 2016-04-22 2017-11-02 ロート製薬株式会社 眼科組成物
JP7159501B1 (ja) * 2016-04-22 2022-10-24 ロート製薬株式会社 眼科組成物
JP7125250B2 (ja) * 2016-04-22 2022-08-24 ロート製薬株式会社 眼科組成物
JP7387835B2 (ja) * 2016-04-22 2023-11-28 ロート製薬株式会社 眼科組成物
US11583496B2 (en) 2016-10-12 2023-02-21 PS Therapy Inc. Drug vehicle compositions and methods of use thereof
US11260035B2 (en) 2016-10-12 2022-03-01 Ps Therapies Ltd Topical compositions and methods of use thereof
JP6983361B2 (ja) * 2019-04-26 2021-12-17 参天製薬株式会社 眼科用製品、およびその利用
TW202320815A (zh) * 2021-09-30 2023-06-01 日商樂敦製藥股份有限公司 眼科組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8916625D0 (en) * 1989-07-20 1989-09-06 Bryce Smith Derek Respiratory tract spray preparations
JP4748289B2 (ja) 2000-06-23 2011-08-17 ライオン株式会社 点眼剤、眼科用組成物及び吸着抑制方法
JP2003146892A (ja) 2001-11-08 2003-05-21 Rohto Pharmaceut Co Ltd 洗浄剤
JP4718160B2 (ja) 2003-11-12 2011-07-06 ロート製薬株式会社 眼科用組成物
US20050137166A1 (en) * 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
JP5403850B2 (ja) 2004-06-08 2014-01-29 ロート製薬株式会社 眼科用清涼組成物
US7629386B2 (en) 2004-08-26 2009-12-08 Bausch + Lomb Incorporated Compositions containing trialkanolamine alkoxylate buffer
JP4953650B2 (ja) * 2005-02-09 2012-06-13 ロート製薬株式会社 プラノプロフェン含有組成物
EP1967186B1 (en) 2005-12-27 2015-03-11 Lion Corporation Composition for soft contact lens and adsorption suppressing method
US8388941B2 (en) 2006-09-28 2013-03-05 Alcon Research, Ltd. Self preserved aqueous pharmaceutical compositions
JP5314349B2 (ja) * 2007-07-25 2013-10-16 ロート製薬株式会社 眼科用組成物
WO2009035034A1 (ja) 2007-09-14 2009-03-19 Rohto Pharmaceutical Co., Ltd. 眼科用組成物
CN101977595A (zh) * 2007-11-08 2011-02-16 阿西克斯医疗公司 用于治疗以及预防眼睑肿胀的组合物
JP2008189677A (ja) 2008-03-10 2008-08-21 Rohto Pharmaceut Co Ltd 洗浄剤
WO2010064636A1 (ja) * 2008-12-02 2010-06-10 ロート製薬株式会社 眼科用組成物
JP4777477B2 (ja) 2009-09-30 2011-09-21 ロート製薬株式会社 点眼剤
JP6313599B2 (ja) * 2011-11-01 2018-04-18 ロート製薬株式会社 眼科用水性組成物

Also Published As

Publication number Publication date
WO2013065720A1 (ja) 2013-05-10
JP2017052804A (ja) 2017-03-16
US20140308368A1 (en) 2014-10-16
JPWO2013065720A1 (ja) 2015-04-02
JP6242998B2 (ja) 2017-12-06
CA2853235A1 (en) 2013-05-10
JP6313599B2 (ja) 2018-04-18
US9173945B2 (en) 2015-11-03

Similar Documents

Publication Publication Date Title
IN2014CN03950A (ja)
PH12017501306A1 (en) Inhibitors of histone demethylases
WO2012071411A3 (en) Nk cell modulating treatments and methods for treatment of hematological malignancies
WO2012065022A3 (en) Spiro-oxindole mdm2 antagonists
MX2014001218A (es) Tratamiento de cancer de mama.
AU2012265219A8 (en) Compounds containing hydrido-tricyano-borate anions
PT2869854T (pt) Composição contendo ectoína ou hidroxiectoína como substância ativa, para promover a regeneração de tecido corporal lesionado
MX2015015356A (es) Formulacion estabilizada de pemetrexed.
EP3486252A4 (en) COMPOSITION FOR PROTECTION OF CELLS CONTAINING CYCLO-HISTIDINE-PROLINE AS ACTIVE INGREDIENT
JO3154B1 (ar) عوامل مضادة لـ trpv4
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
MY161601A (en) Films and compositions comprising the same
EP2887800A4 (en) CONTAINER FOR BLOOD CONSERVATION CONTAINING AN AQUEOUS COMPOSITION FOR THE PRESERVATION OF RED GLOBLES
MX2015011359A (es) Inhibidores macrociclicos de cinasa 2 de repeticion rica en leucina (lrrk2).
MX2015012526A (es) Inhibodores macrociclicos de cinasa rip2.
EP3677269A4 (en) Cartilage regeneration composition with HAPLN1 as the active ingredient
PH12014502500B1 (en) (r)-nifuratel, its use for the treatment of infections and synthesis of (r) and (s)-nifuratel
EP3104861A4 (en) Bifunctional compounds and use for reducing uric acid levels
WO2014145236A3 (en) The use of sdf-1 to mitigate scar formation
EP3247704A4 (en) Bifunctional compounds and use for reducing uric acid levels
WO2012173382A3 (ko) 탄시논ⅱａ를 유효성분으로 함유하는 피부 외용제 조성물
EP2905337A4 (en) AMPHIREGULIN SPECIFIC DOUBLE HELIX OLIGO RNA, DOUBLE HELIX OLIGO RNA STRUCTURE WITH THE DOUBLE HELIX OLIGO RNA AND COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASES THEREWITH
EP2910246A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CANCER WITH ENOBLOCK AS AN ACTIVE SUBSTANCE
WO2011113785A3 (en) A cosmetic composition for rejuvenating skin appearance
MX2013008635A (es) Mejoras de y relacionadas con composiciones.